ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Down 7.8% in December

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) was the recipient of a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 5,950,000 shares, a decrease of 7.8% from the November 30th total of 6,450,000 shares. Based on an average daily volume of 4,970,000 shares, the days-to-cover ratio is currently 1.2 days. Currently, 12.8% of the shares of the company are short sold.

Analyst Ratings Changes

ASPI has been the topic of several research analyst reports. Canaccord Genuity Group reaffirmed a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 target price on the stock.

Check Out Our Latest Research Report on ASPI

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI traded down $0.05 during midday trading on Wednesday, reaching $4.53. 1,943,606 shares of the company were exchanged, compared to its average volume of 1,900,932. The stock has a market cap of $323.40 million, a P/E ratio of -7.43 and a beta of 3.27. ASP Isotopes has a 1 year low of $1.65 and a 1 year high of $9.33. The stock has a fifty day simple moving average of $5.93 and a 200 day simple moving average of $3.94. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in shares of ASP Isotopes during the third quarter worth approximately $6,249,000. Telemark Asset Management LLC acquired a new position in ASP Isotopes in the 3rd quarter valued at $4,726,000. Geode Capital Management LLC raised its position in ASP Isotopes by 42.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock worth $3,110,000 after buying an additional 334,836 shares during the last quarter. Philadelphia Financial Management of San Francisco LLC lifted its stake in shares of ASP Isotopes by 158.3% in the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after acquiring an additional 607,893 shares during the period. Finally, State Street Corp boosted its holdings in shares of ASP Isotopes by 12.8% in the third quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after acquiring an additional 96,604 shares in the last quarter. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

See Also

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.